This is your one stop shop for updates on CTTI projects, developments in the clinical trials enterprise and other relevant news. To read the full-length entry, or to share a specific blog post, click on the title of the article of interest.
CTTI is seeking a qualified patient representative to fill one of two designated patient seats on its Steering Committee. Interested candidates should read the informational materials below to gain an understanding of the Patient Representative responsibilities and submit the required materials to CTTI@duke.edu by 5:00pm on October 12, 2012 for consideration.
Click here to view a PDF of the slide set that provides background on ClinicalTrials.gov and the AACT database, as well as an overview of the clinical trials enterprise as revealed by ClinicalTrials.gov. The PowerPoint slide set is also available for download here .
The Clinical Trials Transformation Initiative (CTTI) has named a 14-member Executive Committee , resetting CTTI's strategic direction, and ensuring that the organization informs and facilitates meaningful improvements to clinical trial design and conduct.
"Clinical trials are a critical component of how we develop medical evidence, and they are not meeting the societal need for answers about which strategies and therapies are most effective," said Robert Califf, M.D., co-chair of the CTTI Executive Committee, vice chancellor for clinical and translational research at Duke...
On August 13, 2012, visitors to the ClinicalTrials.gov website and the accompanying Protocol Registration System (PRS) Information Web site (designed for data providers) saw a link to a beta site including a new integrated homepage and updated graphic design for the site ( http://clinicaltrials.gov/beta/) . (The last major redesign of ClinicalTrials.gov was introduced in September 2007. For more information, see New Look for ClinicalTrials.gov .) Visitors will also have access to new and reorganized written content about clinical research, background information about the site, searching...
The Clinical Trials Transformation Initiative (CTTI) recently held an expert meeting to discuss known barriers of central IRBs for mulitcenter clinical trials and possible solutions to obviate these barriers. The expert meeting called representatives from a broad cross-section of the clinical trial enterprise, including government and industry sponsors of clinical research, academic and non-academic research institutions, commercial IRBs, and patient advocates.
The key objectives of this meeting were to: